INHIBITION BY NIMESULIDE OF PROSTAGLANDIN PRODUCTION IN RAT MACROPHAGES

Citation
Y. Taniguchi et al., INHIBITION BY NIMESULIDE OF PROSTAGLANDIN PRODUCTION IN RAT MACROPHAGES, Drugs under experimental and clinical research, 24(1), 1998, pp. 17-27
Citations number
43
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
03786501
Volume
24
Issue
1
Year of publication
1998
Pages
17 - 27
Database
ISI
SICI code
0378-6501(1998)24:1<17:IBNOPP>2.0.ZU;2-K
Abstract
We have investigated the inhibitory action of nimesulide (4-nitro-2-ph enoxymethanesulfonanilide) an release of prostaglandin E-2 (PGE(2)) fr om rat peritoneal exudated macrophages (macrophages) and its mechanism of action. PGE(2) release from macrophages stimulated with opsonized zymosan (OPZ) were increased in the 20 h after stimulation, whereas no significant increase was noted in PGE(2) release from unstimulated ma crophages. Nimesulide caused a weak inhibition of PGE(2) release from macrophages at 15 min after OPZ stimulation as compared with indometha cin, but nimesulide caused approximately the same strong inhibition as indomethacin at 10 h after OPZ stimulation. Cellular cyclooxygenase ( COX) activity in macrophages at 10 h after OPZ stimulation was increas ed approximately seven times the COX activity in macrophages before OP Z stimulation. Nimesulide caused approximately the same strong inhibit ion of cellular COX activity as indomethacin at 10 h after OPZ stimula tion. COX-1 mRNA was expressed in macrophages irrespective of OPZ stim ulation, but COX-2 mRNA was expressed only after OPZ stimulation, and COX-2 protein was simultaneously induced. Nimesulide affected neither the levels of COX-1 mRNA and COX-2 mRNA at 4 h after OPZ stimulation n or the levels of COX-2 protein at 10 h after OPZ stimulation. In contr ast, actinomycin D caused strong inhibition of COX-2 mRNA expression a nd protein induction. These results suggest that inhibition by nimesul ide of PGE(2) release from macrophages, namely inflammatory cells, wou ld be neither due to inhibition of COX-2 mRNA expression nor COX-2 ind uction, but to the selective inhibition of COX-2 activity itself.